GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
117.4K views | +0 today
Follow
GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Your new post is loading...
Your new post is loading...
Rescooped by Lionel Reichardt / le Pharmageek from healthcare technology
Scoop.it!

Grant awarded to develop artificial intelligence to improve stroke screening and treatment in smaller hospitals

Grant awarded to develop artificial intelligence to improve stroke screening and treatment in smaller hospitals | GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK | Scoop.it

New artificial intelligence technology that uses a common CT angiography (CTA), as opposed to the more advanced imaging normally required to help identify patients who could benefit from endovascular stroke therapy (EST), is being developed at The University of Texas Health Science Center at Houston (UTHealth).

 

Two UTHealth researchers worked together to create a machine-learning artificial intelligence tool that could be used for assessing a stroke at every hospital that takes care of stroke patients - not just at large academic hospitals in major cities. 

 

Research to further develop and test the technology tool is funded through a five-year, $2.5 million grant from the National Institutes of Health (NIH). 

 

"The vast majority of stroke patients don't show up at large hospitals, but in those smaller regional facilities. And most of the emphasis on screening techniques is only focused on the technologies used in those large academic centers. With this technology, we are looking to change that," said Sunil Sheth, MD, assistant professor of neurology at McGovern Medical School at UTHealth.

 

Sheth set out with Luca Giancardo, PhD, assistant professor with the Center for Precision Health at UTHealth School of Biomedical Informatics, to develop a quicker way to assess patients. The result was a novel deep neural network architecture that leverages brain symmetry. Using CTAs, which are more widely available, the system can determine the presence or absence of a large vessel occlusion and whether the amount of "at-risk" tissue is above or below the thresholds seen in those patients who benefitted from EST in the clinical trials.

 

"This is the first time a data set is being specifically collected aiming to address the lack of quality imaging available for stroke patients at smaller hospitals," Giancardo said.

 

read the complete press release with further details on the work at https://www.uth.edu/news/story.htm?id=9fccdefb-ff91-4775-a759-a786689956ea

 


Via nrip
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from healthcare technology
Scoop.it!

AI Software Writing AI Software For Healthcare?  #hcsmeufr #esante #digitalhealth

AI Software Writing AI Software For Healthcare?  #hcsmeufr #esante #digitalhealth | GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK | Scoop.it

At the World Medical Innovation Forum this week, participants were polled with a loaded question:

“Do you think healthcare will become better or worse from the use of AI?”

Across the respondents, 98 percent said it would be either “Better” or “Much Better” and not a single one thought it would become “Much Worse.” This is an interesting statistic, and the results were not entirely surprising, especially given that artificial intelligence was the theme for the meeting.

This continual stream of adoption of new technologies in both clinical and post clinical settings is remarkable. Today, healthcare is a technology operation. As a case in point, outside of the array of MDs and medical professionals presenting at the forum, there was clearly a strong, advanced technology thread weaved throughout the conversations of the traditional topics of pathology, radiology, bioinformatics, electronic medical records (EMR), and standard healthcare provider issues.

As an example, a panel of senior technology experts from Microsoft, Cisco Systems, Dell EMC, Qualcomm, and Google joined research and information officers from Partners Healthcare and Massachusetts General Hospital to discuss the challenges in what they called “Data Engineering in Healthcare: Liberating Value.” That is a serious title for a panel.

Data portability was clearly a key topic, as was security and the public cloud.

The underlying issue with the cloud is that the EMR was never really designed to be portable.

Health records existed with institutional walls, and were not originally intended for real time care, but more as a means of tracking costs and transactions as the patient traveled through the various systems. As the EMR has not only become more feature rich, the ability to mine that data inside of them with ML and AI methods is clearly at the forefront of everyone’s mind right now.

There was discussion of episodic systems wrapped in policy and technology – this really isn’t quite how we can gain the maximum knowledge from the healthcare version of a Digital Me. A digital object containing all of our many and varied health related attributes. The challenges of discussing how to best build a “marketplace” and healthcare data exchanges and how to integrate “data marts” with existing EMR systems was obvious.


Via nrip
nrip's curator insight, April 30, 2018 7:13 PM

AI can help clinicians and nurses do their job better. AI will never replace doctors, but doctors which use AI will replace doctors who dont.

Rescooped by Lionel Reichardt / le Pharmageek from healthcare technology
Scoop.it!

AI and ML can revolutionize life sciences, and biology can move AI further ahead

AI and ML can revolutionize life sciences, and biology can move AI further ahead | GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK | Scoop.it

Two scientific leaps,  in machine learning algorithms and powerful biological imaging and sequencing tools , are increasingly being combined to spur progress in understanding diseases and advance AI itself.

 

Cutting-edge, machine-learning techniques are increasingly being adapted and applied to biological data, including for COVID-19.

 

Recently, researchers reported using a new technique to figure out how genes are expressed in individual cells and how those cells interact in people who had died with Alzheimer's disease.

 

Machine-learning algorithms can also be used to compare the expression of genes in cells infected with SARS-CoV-2 to cells treated with thousands of different drugs in order to try to computationally predict drugs that might inhibit the virus.

 

While, Algorithmic results alone don't prove the drugs are potent enough to be clinically effective. But they can help identify future targets for antivirals or they could reveal a protein researchers didn't know was important for SARS-CoV-2, providing new insight on the biology of the virus

 

read the original article which speaks about a lot more at https://www.axios.com/ai-machine-learning-biology-drug-development-b51d18f1-7487-400e-8e33-e6b72bd5cfad.html

 

 


Via nrip
nrip's curator insight, April 15, 2021 10:26 AM

The insight in this article is shared among a number of early adopters and tinkerers in the Healthcare ML space. A number of specific problems which are being worked on within the Machine learning space which relate to life sciences are stimulants which help us advance the science of machine learning much faster than other areas.

 

This is because the science of Biology requires more than patterns being found and re-applied to identify something. It requires understanding the interaction of all the contributing factors behind that pattern being created in the first place. So, creating a drug to target a protein involved in a disease does require understanding how the genes that give rise to that protein are regulated.